48 related articles for article (PubMed ID: 3006962)
1. Characterization of cells from human giant cell tumors of bone.
Goldring SR; Schiller AL; Mankin HJ; Dayer JM; Krane SM
Clin Orthop Relat Res; 1986 Mar; (204):59-75. PubMed ID: 3006962
[TBL] [Abstract][Full Text] [Related]
2. Intratibial injection of patient-derived tumor cells from giant cell tumor of bone elicits osteolytic reaction in nude mouse.
Xu L; Wu Z; Zhou Z; Yang X; Xiao J
Oncol Lett; 2018 Oct; 16(4):4649-4655. PubMed ID: 30214599
[TBL] [Abstract][Full Text] [Related]
3. Giant Cell Tumor of the Mobile Spine Occurring in Pregnancy: A Case Report and Literature Review.
Zheng K; Xu M; Wang B; Yu XC; Hu YC
Orthop Surg; 2017 May; 9(2):252-256. PubMed ID: 28547859
[TBL] [Abstract][Full Text] [Related]
4. 3-Dimensional micropillar drug screening identifies FGFR2-IIIC overexpression as a potential target in metastatic giant cell tumor.
Kim ST; Kim J; Shin S; Kim SY; Lee D; Ku B; Shin YS; Kim J; Lee J
Oncotarget; 2017 May; 8(22):36484-36491. PubMed ID: 28445128
[TBL] [Abstract][Full Text] [Related]
5. Characterization of MicroRNA Expression Profiles in Patients with Giant Cell Tumor.
Qin S; He NB; Yan HL; Dong Y
Orthop Surg; 2016 May; 8(2):212-9. PubMed ID: 27384730
[TBL] [Abstract][Full Text] [Related]
6. Rare Presentation of Giant Cell Tumor in the Internal Auditory Canal: Case Report and Review of the Literature.
Jada AS; Shrivastava RK; Mannan A; Kobets A; Manolidis S
J Neurol Surg Rep; 2015 Jul; 76(1):e65-71. PubMed ID: 26251814
[TBL] [Abstract][Full Text] [Related]
7. Enrichment of c-Met+ tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinib.
Liu L; Aleksandrowicz E; Fan P; Schönsiegel F; Zhang Y; Sähr H; Gladkich J; Mattern J; Depeweg D; Lehner B; Fellenberg J; Herr I
Cell Death Dis; 2014 Oct; 5(10):e1471. PubMed ID: 25321478
[TBL] [Abstract][Full Text] [Related]
8. Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement.
Gao ZH; Yin JQ; Xie XB; Zou CY; Huang G; Wang J; Shen JN
BMC Musculoskelet Disord; 2014 Oct; 15():330. PubMed ID: 25277133
[TBL] [Abstract][Full Text] [Related]
9. Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy.
Steensma MR; Tyler WK; Shaber AG; Goldring SR; Ross FP; Williams BO; Healey JH; Purdue PE
PLoS One; 2013; 8(7):e69101. PubMed ID: 23922683
[TBL] [Abstract][Full Text] [Related]
10. Expressional Analysis of GFP-Tagged Cells in an In Vivo Mouse Model of Giant Cell Tumor of Bone.
Singh S; Singh M; Mak I; Ghert M
Open Orthop J; 2013; 7():109-13. PubMed ID: 23730372
[TBL] [Abstract][Full Text] [Related]
11. p63 regulates cell proliferation and cell cycle progression‑associated genes in stromal cells of giant cell tumor of the bone.
Lau CP; Ng PK; Li MS; Tsui SK; Huang L; Kumta SM
Int J Oncol; 2013 Feb; 42(2):437-43. PubMed ID: 23229819
[TBL] [Abstract][Full Text] [Related]
12. Investigation of FGFR2-IIIC signaling via FGF-2 ligand for advancing GCT stromal cell differentiation.
Singh S; Singh M; Mak IW; Turcotte R; Ghert M
PLoS One; 2012; 7(10):e46769. PubMed ID: 23071632
[TBL] [Abstract][Full Text] [Related]
13. Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor.
Kim Y; Nizami S; Goto H; Lee FY
Clin Orthop Surg; 2012 Jun; 4(2):107-16. PubMed ID: 22662295
[TBL] [Abstract][Full Text] [Related]
14. Collagenase expression and activity in the stromal cells from giant cell tumour of bone.
Cowan RW; Mak IW; Colterjohn N; Singh G; Ghert M
Bone; 2009 May; 44(5):865-71. PubMed ID: 19442604
[TBL] [Abstract][Full Text] [Related]
15. Giant cell tumor of bone: a neoplasm or a reactive condition?
Haque AU; Moatasim A
Int J Clin Exp Pathol; 2008 Jan; 1(6):489-501. PubMed ID: 18787633
[TBL] [Abstract][Full Text] [Related]
16. Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone.
Rao VH; Singh RK; Bridge JA; Neff JR; Schaefer GB; Delimont DC; Dunn CM; Sanger WG; Buehler BA; Sawaya R; Nicolson GL; Rao JS
Clin Exp Metastasis; 1997 Jul; 15(4):400-9. PubMed ID: 9219728
[TBL] [Abstract][Full Text] [Related]
17. Multinucleated cells in pigmented villonodular synovitis and giant cell tumor of tendon sheath express features of osteoclasts.
Darling JM; Goldring SR; Harada Y; Handel ML; Glowacki J; Gravallese EM
Am J Pathol; 1997 Apr; 150(4):1383-93. PubMed ID: 9094994
[TBL] [Abstract][Full Text] [Related]
18. Low content of estrogen receptors in human giant cell tumors of bone.
Ishibe M; Ishibe Y; Ishibashi T; Nojima T; Rosier RN; Puzas JE; Kaneda K
Arch Orthop Trauma Surg; 1994; 113(2):106-9. PubMed ID: 8186044
[TBL] [Abstract][Full Text] [Related]
19. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.
Zheng MH; Fan Y; Wysocki SJ; Lau AT; Robertson T; Beilharz M; Wood DJ; Papadimitriou JM
Am J Pathol; 1994 Nov; 145(5):1095-104. PubMed ID: 7977641
[TBL] [Abstract][Full Text] [Related]
20. Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction.
Gorn AH; Rudolph SM; Flannery MR; Morton CC; Weremowicz S; Wang TZ; Krane SM; Goldring SR
J Clin Invest; 1995 Jun; 95(6):2680-91. PubMed ID: 7769107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
